¡ã »óÁö´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾à¸®Çб³½Ç ¿¬±¸Áø. |
»óÁö´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾à¸®Çб³½Ç(¿¬±¸Ã¥ÀÓÀÚ: ¾ÈÈ¿Áø ±³¼ö)ÀÌ ÃÖ±Ù ¹ßÇ¥ÇÑ ¿¬±¸³»¿ëÀ» ÇÇÀοëÁö¼ö 5Á¡ ÀÌ»ó ³í¹®À¸·Î °ÔÀçÇÏ´Â Äè°Å¸¦ °Åµ×´Ù.
ÇÇÀοëÁö¼ö(IF. Impact Factor)´Â ÇмúÁö¿¡ °ÔÀçµÈ ³í¹®ÀÌ Àü ¼¼°è ´Ù¸¥ ¿¬±¸ÀÚ¿¡ ÀοëµÇ´Â Á¤µµ¸¦ °è»êÇØ ¼öÄ¡ÈÇÑ °ªÀÌ´Ù. ÇмúÀâÁöÀÇ ¿µÇâ·ÂÀ» ÃøÁ¤ÇÏ´Â ÁöÇ¥·Î ¾²ÀδÙ.
»óÁö´ë¿¡ µû¸£¸é ÇÇÀοëÁö¼ö 5Á¡ ÀÌ»ó ¿¬±¸´Â ¢¹ÀÚ¼Ò¿± ¼ººÐÀ¸·Î ´ëÀå¾Ï È¿´ÉÀ» È®ÀÎÇÑ ‘Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis (Neoplasia Àú³Î, ÇÇÀοëÁö¼ö: 5.715)’ ¢¹ºñ¸¸¿¡¼ ´ëÇ¥Àû º¸Ç÷ÇѾàÀçÀÎ ´ç±ÍÀÇ ÁÖ¼ººÐÀÎ nodakeninÀÇ È¿´ÉÀ» È®ÀÎÇÑ ‘Nodakenin represses obesity and its complications via the inhibition of the VLDLR signalling pathway in vivo and in vitro (Cell proliferation Àú³Î, ÇÇÀοëÁö¼ö: 6.831)’ ¢¹Ã»¿ ¾àÀçÀΠȲ±ÝÀÇ berberineÀÇ Àü¸³¼± ºñ´ë¿¡ ´ëÇÑ È¿´ÉÀ» ¿¬±¸ÇÑ ‘Oral administration of Berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB (Aging-us Àú³Î, ÇÇÀοëÁö¼ö: 5.682)’ µîÀÌ´Ù. ¸ðµÎ ¿ÃÇØ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇÑ Áøº¸¶÷ ¾¾°¡ Á¦1ÀúÀÚ·Î Âü¿©ÇÑ ³í¹®µéÀÌ´Ù.
¶ÇÇÑ ´ëÇпø ¹Ú»ç°úÁ¤¿¡ ÀçÇÐ ÁßÀÎ ¹Ú¿¹Áø ¾¾°¡ ÁÖÀúÀÚÀÎ ‘Therapeutic effects of Gambi-jung for the treatment of obesity’µµ ÇÇÀοëÁö¼ö 6.529Á¡À¸·Î ÇаèÀÇ ÁÖ¸ñÀ» ¹Þ°í ÀÖ´Ù. °¨ºñÁ¤ÀÇ Ç׺ñ¸¸ È¿´ÉÀ» ±Ô¸íÇÑ ÀÌ ¿¬±¸´Â ÇÑÀÇÇÐÀû º¹ÇÕó¹æÀ» È°¿ë, ±¹Á¦ Àú³Î¿¡ °ÔÀçÇϱâ Èûµç ½ÇÁ¤ÀÓ¿¡µµ ºÐ¸íÇÑ °á°ú¿Í ¸íÈ®ÇÑ ±âÀü±Ô¸íÀ» ¹ÙÅÁÀ¸·Î Biomedicine&Phamacology Àú³Î¿¡ ´ç´çÈ÷ ½Ç¸®´Â ¼º°ú¸¦ °Åµ×´Ù.
ÇÑÆí »óÁö´ë ¾à¸®Çб³½ÇÀº Àü¸³¼±Áúȯ, ºñ¸¸, ´ëÀåÁúȯ, ÇǺÎÁúȯ µîÀÇ ¸ðµ¨À» ±¸ÃàÇÏ°í, À̸¦ ÀÌ¿ëÇÑ ÇÑÀDZٰŠ¼ÒÀçÀÇ È¿´ÉÆò°¡¸¦ ÁøÇàÇÏ´Â ¿¬±¸¸¦ ÁøÇàÇÏ°í ÀÖÀ¸¸ç, À̸¦ ±â¹ÝÀ¸·Î ´Ù¾çÇÑ ±¹°¡ ¿¬±¸ °úÁ¦¸¦ ¼öÇàÇÏ°í ÀÖ´Ù.
¾ÈÈ¿Áø ±³¼ö´Â “ÇÑÀǾàÀÇ ±Ù°ÅÈ¿Í ¼¼°èȸ¦ À§ÇØ °è¼ÓÇؼ ¿¬±¸¿¡ Èû¾²¸ç, »óÁö´ëÇб³ ¿¬±¸ ¿ª·® °È¿¡ ÀÏÁ¶ÇÏ°Ú´Ù”°í ¹àÇû´Ù.
±è¹ÎÈ£ ±âÀÚ hana016@hanmail.net